Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ABPWW vs AGEN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ABPWW
Abpro Holdings Inc

Biotechnology

HealthcareNASDAQ • US
Market Cap$627.00
5Y Perf.-95.5%
AGEN
Agenus Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$132M
5Y Perf.-17.0%

ABPWW vs AGEN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ABPWW logoABPWW
AGEN logoAGEN
IndustryBiotechnologyBiotechnology
Market Cap$627.00$132M
Revenue (TTM)$183K$114M
Net Income (TTM)$-14M$115K
Gross Margin-55.2%35.7%
Operating Margin-79.5%-17.7%
Forward P/E1.8x
Total Debt$3M$10M
Cash & Equiv.$3M$3M

ABPWW vs AGENLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ABPWW
AGEN
StockNov 24Apr 26Return
Abpro Holdings Inc (ABPWW)1004.5-95.5%
Agenus Inc. (AGEN)10083.0-17.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: ABPWW vs AGEN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AGEN leads in 3 of 5 categories, making it the strongest pick for profitability and margin quality and recent price momentum and sentiment. Abpro Holdings Inc is the stronger pick specifically for growth and revenue expansion. As sector peers, any of these can serve as alternatives in the same allocation.
ABPWW
Abpro Holdings Inc
The Growth Play

ABPWW is the clearest fit if your priority is growth exposure.

  • Rev growth 50.0%, EPS growth 38.4%, 3Y rev CAGR -27.5%
  • 50.0% revenue growth vs AGEN's 10.4%
Best for: growth exposure
AGEN
Agenus Inc.
The Long-Run Compounder

AGEN carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • -94.3% 10Y total return vs ABPWW's -95.0%
  • Lower volatility, beta 2.72, current ratio 0.41x
  • Beta 2.72, current ratio 0.41x
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthABPWW logoABPWW50.0% revenue growth vs AGEN's 10.4%
Quality / MarginsAGEN logoAGEN0.1% margin vs ABPWW's -76.7%
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)AGEN logoAGEN+27.1% vs ABPWW's -90.0%
Efficiency (ROA)AGEN logoAGEN0.1% ROA vs ABPWW's -8.2%

ABPWW vs AGEN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ABPWWAbpro Holdings Inc

Segment breakdown not available.

AGENAgenus Inc.
FY 2025
Non Cash Royalty Revenue
99.1%$109M
Other
0.9%$1M

ABPWW vs AGEN — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAGENLAGGINGABPWW

Income & Cash Flow (Last 12 Months)

AGEN leads this category, winning 5 of 5 comparable metrics.

AGEN is the larger business by revenue, generating $114M annually — 624.0x ABPWW's $183,000. AGEN is the more profitable business, keeping 0.1% of every revenue dollar as net income compared to ABPWW's -76.7%.

MetricABPWW logoABPWWAbpro Holdings IncAGEN logoAGENAgenus Inc.
RevenueTrailing 12 months$183,000$114M
EBITDAEarnings before interest/tax-$11M-$10M
Net IncomeAfter-tax profit-$14M$115,000
Free Cash FlowCash after capex-$14M-$159M
Gross MarginGross profit ÷ Revenue-55.2%+35.7%
Operating MarginEBIT ÷ Revenue-79.5%-17.7%
Net MarginNet income ÷ Revenue-76.7%+0.1%
FCF MarginFCF ÷ Revenue-74.5%-139.1%
Rev. Growth (YoY)Latest quarter vs prior year+27.5%
EPS Growth (YoY)Latest quarter vs prior year+41.2%+85.3%
AGEN leads this category, winning 5 of 5 comparable metrics.

Valuation Metrics

Evenly matched — ABPWW and AGEN each lead in 1 of 2 comparable metrics.
MetricABPWW logoABPWWAbpro Holdings IncAGEN logoAGENAgenus Inc.
Market CapShares × price$627$132M
Enterprise ValueMkt cap + debt − cash$478,627$140M
Trailing P/EPrice ÷ TTM EPS-0.00x-1102.94x
Forward P/EPrice ÷ next-FY EPS est.1.79x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue0.00x1.16x
Price / BookPrice ÷ Book value/share
Price / FCFMarket cap ÷ FCF
Evenly matched — ABPWW and AGEN each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

AGEN leads this category, winning 3 of 5 comparable metrics.

On the Piotroski fundamental quality scale (0–9), AGEN scores 6/9 vs ABPWW's 3/9, reflecting solid financial health.

MetricABPWW logoABPWWAbpro Holdings IncAGEN logoAGENAgenus Inc.
ROE (TTM)Return on equity
ROA (TTM)Return on assets-8.2%+0.1%
ROICReturn on invested capital
ROCEReturn on capital employed
Piotroski ScoreFundamental quality 0–936
Debt / EquityFinancial leverage
Net DebtTotal debt minus cash$478,000$7M
Cash & Equiv.Liquid assets$3M$3M
Total DebtShort + long-term debt$3M$10M
Interest CoverageEBIT ÷ Interest expense-10.64x1.11x
AGEN leads this category, winning 3 of 5 comparable metrics.

Total Returns (Dividends Reinvested)

AGEN leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in AGEN five years ago would be worth $611 today (with dividends reinvested), compared to $500 for ABPWW. Over the past 12 months, AGEN leads with a +27.1% total return vs ABPWW's -90.0%. The 3-year compound annual growth rate (CAGR) favors AGEN at -51.0% vs ABPWW's -63.2% — a key indicator of consistent wealth creation.

MetricABPWW logoABPWWAbpro Holdings IncAGEN logoAGENAgenus Inc.
YTD ReturnYear-to-date-86.5%+16.1%
1-Year ReturnPast 12 months-90.0%+27.1%
3-Year ReturnCumulative with dividends-95.0%-88.2%
5-Year ReturnCumulative with dividends-95.0%-93.9%
10-Year ReturnCumulative with dividends-95.0%-94.3%
CAGR (3Y)Annualised 3-year return-63.2%-51.0%
AGEN leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ABPWW and AGEN each lead in 1 of 2 comparable metrics.

ABPWW is the less volatile stock with a -1.33 beta — it tends to amplify market swings less than AGEN's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AGEN currently trades 51.1% from its 52-week high vs ABPWW's 2.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricABPWW logoABPWWAbpro Holdings IncAGEN logoAGENAgenus Inc.
Beta (5Y)Sensitivity to S&P 500-1.33x2.72x
52-Week HighHighest price in past year$0.07$7.34
52-Week LowLowest price in past year$0.00$2.71
% of 52W HighCurrent price vs 52-week peak+2.7%+51.1%
RSI (14)Momentum oscillator 0–10043.548.8
Avg Volume (50D)Average daily shares traded2K814K
Evenly matched — ABPWW and AGEN each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricABPWW logoABPWWAbpro Holdings IncAGEN logoAGENAgenus Inc.
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$7.33
# AnalystsCovering analysts11
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.1%
Insufficient data to determine a leader in this category.
Key Takeaway

AGEN leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.

Best OverallAgenus Inc. (AGEN)Leads 3 of 6 categories
Loading custom metrics...

ABPWW vs AGEN: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is ABPWW or AGEN a better buy right now?

For growth investors, Abpro Holdings Inc (ABPWW) is the stronger pick with 50.

0% revenue growth year-over-year, versus 10. 4% for Agenus Inc. (AGEN). Analysts rate Agenus Inc. (AGEN) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ABPWW or AGEN?

Over the past 5 years, Agenus Inc.

(AGEN) delivered a total return of -93. 9%, compared to -95. 0% for Abpro Holdings Inc (ABPWW). Over 10 years, the gap is even starker: AGEN returned -94. 3% versus ABPWW's -95. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ABPWW or AGEN?

By beta (market sensitivity over 5 years), Abpro Holdings Inc (ABPWW) is the lower-risk stock at -1.

33β versus Agenus Inc. 's 2. 72β — meaning AGEN is approximately -305% more volatile than ABPWW relative to the S&P 500.

04

Which is growing faster — ABPWW or AGEN?

By revenue growth (latest reported year), Abpro Holdings Inc (ABPWW) is pulling ahead at 50.

0% versus 10. 4% for Agenus Inc. (AGEN). On earnings-per-share growth, the picture is similar: Agenus Inc. grew EPS 100. 0% year-over-year, compared to 38. 4% for Abpro Holdings Inc. Over a 3-year CAGR, AGEN leads at 5. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ABPWW or AGEN?

Agenus Inc.

(AGEN) is the more profitable company, earning 0. 1% net margin versus -39. 5% for Abpro Holdings Inc — meaning it keeps 0. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AGEN leads at -18. 0% versus -54. 2% for ABPWW. At the gross margin level — before operating expenses — ABPWW leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — ABPWW or AGEN?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is ABPWW or AGEN better for a retirement portfolio?

For long-horizon retirement investors, Abpro Holdings Inc (ABPWW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1.

33)). Agenus Inc. (AGEN) carries a higher beta of 2. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ABPWW: -95. 0%, AGEN: -94. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between ABPWW and AGEN?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ABPWW is a small-cap high-growth stock; AGEN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ABPWW

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $500M
  • Revenue Growth > 25%
Run This Screen
Stocks Like

AGEN

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Gross Margin > 21%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ABPWW and AGEN on the metrics below

Revenue Growth>
%
(ABPWW: 50.0% · AGEN: 27.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.